News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,198 Results
Type
Article (53685)
Company Profile (290)
Press Release (692223)
Section
Business (215925)
Career Advice (2880)
Deals (37345)
Drug Delivery (112)
Drug Development (86117)
Employer Resources (182)
FDA (17078)
Job Trends (15879)
News (366957)
Policy (35545)
Tag
Academia (2907)
Alliances (52828)
Alzheimer's disease (1390)
Approvals (17019)
Artificial intelligence (201)
Bankruptcy (381)
Best Places to Work (12195)
Biotechnology (206)
Breast cancer (228)
Cancer (1694)
Cardiovascular disease (137)
Career advice (2414)
CAR-T (125)
Cell therapy (355)
Clinical research (68980)
Collaboration (648)
Compensation (333)
COVID-19 (2770)
C-suite (155)
Data (1551)
Diabetes (212)
Diagnostics (6608)
Earnings (87241)
Employer resources (158)
Events (117489)
Executive appointments (560)
FDA (17931)
Funding (586)
Gene therapy (250)
GLP-1 (733)
Government (4805)
Healthcare (20083)
Infectious disease (2879)
Inflammatory bowel disease (127)
Interviews (556)
IPO (16925)
Job creations (4131)
Job search strategy (1996)
Layoffs (481)
Legal (8743)
Lung cancer (256)
Manufacturing (243)
Medical device (13928)
Medtech (13933)
Mergers & acquisitions (20727)
Metabolic disorders (576)
Neuroscience (1817)
NextGen: Class of 2025 (7143)
Non-profit (4909)
Northern California (1976)
Obesity (329)
Opinion (237)
Patents (147)
People (61600)
Phase I (21400)
Phase II (30255)
Phase III (22638)
Pipeline (665)
Postmarket research (2944)
Preclinical (9137)
Radiopharmaceuticals (250)
Rare diseases (331)
Real estate (6445)
Regulatory (23747)
Research institute (2570)
Resumes & cover letters (456)
Southern California (1710)
Startups (3872)
United States (17955)
Vaccines (674)
Weight loss (242)
Date
Today (158)
Last 7 days (640)
Last 30 days (2934)
Last 365 days (36192)
2025 (3059)
2024 (36706)
2023 (41643)
2022 (52872)
2021 (57578)
2020 (56498)
2019 (49771)
2018 (37674)
2017 (34551)
2016 (34485)
2015 (40528)
2014 (34459)
2013 (29885)
2012 (31934)
2011 (32513)
2010 (30634)
Location
Africa (926)
Arizona (215)
Asia (42357)
Australia (7703)
California (4544)
Canada (1637)
China (386)
Colorado (209)
Connecticut (216)
Europe (94679)
Florida (654)
Georgia (164)
Illinois (478)
Indiana (262)
Maryland (742)
Massachusetts (3524)
Michigan (197)
Minnesota (342)
New Jersey (1289)
New York (1302)
North Carolina (878)
Northern California (1976)
Ohio (167)
Pennsylvania (1054)
South America (1309)
Southern California (1711)
Texas (660)
Utah (134)
Washington State (457)
746,198 Results for "novanta inc formerly known as gsi group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Genetown
Novanta to Present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024, in White Plains, New York.
June 18, 2024
·
1 min read
Genetown
Novanta to Present at Baird’s 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird’s 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024, in New York, NY.
May 1, 2024
·
1 min read
Deals
Novanta completes acquisition of Motion Solutions
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has completed the acquisition of Motion Solutions.
January 2, 2024
·
7 min read
Genetown
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.
April 19, 2024
·
1 min read
Business
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024
October 8, 2024
·
1 min read
Business
Novanta Announces Financial Results for the First Quarter 2024
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2024.
May 7, 2024
·
27 min read
Business
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
Novanta Inc. today reported financial results for the fourth quarter and full year 2023.
February 28, 2024
·
34 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Business
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 7, 2023
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2023 results on Tuesday, November 7, 2023.
October 10, 2023
·
1 min read
1 of 74,620
Next
